Evaluation of the Pictura Bio System for Rapid Detection of Respiratory Viruses Using Nasal Swabs in Patients with Suspected Viral Infection

What this Trial Is About

Researchers are exploring the use of the Pictura Bio system, a new rapid pathogen identification technology, to detect and differentiate respiratory viruses from nasal swab or aspirate samples. This study aims to improve upon current virus detection methods, which can be slow, costly, or less sensitive. By training an AI algorithm with patient samples, the system hopes to become accurate enough for clinical use, helping to better understand respiratory virus infections and their impact on healthcare demand during winter seasons. Participants include both adults and children suspected of having respiratory viral infections who present to the emergency department or hospital admission. They will provide nasal or throat swabs as part of clinical care, along with an additional swab for research purposes. The data collected will be used to train and test the AI system, with regular monitoring of its accuracy. The Pictura Bio system is still under development and will improve as it processes more patient information. Throughout the study, basic information such as age, gender, blood test results, treatments, and outcomes will be collected securely. Participants will undergo routine clinical sampling combined with research swabs to reduce extra testing. No results from study-specific swabs will be shared with participants or their clinical teams, ensuring no impact on patient care. The study plans to recruit about 1000 patients and will analyze the prevalence of respiratory viruses and antibiotic use in the community.

Novel Technologies for Respiratory Virus Identification